HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 547 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2023. The put-call ratio across all filers is 3.18 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $512,390 | -88.9% | 4,429 | -90.1% | 0.00% | -100.0% |
| Q2 2023 | $4,617,554 | -16.0% | 44,896 | -10.9% | 0.00% | -20.0% |
| Q1 2023 | $5,499,127 | -0.3% | 50,386 | +4.0% | 0.01% | 0.0% |
| Q4 2022 | $5,514,066 | +58.6% | 48,454 | -13.7% | 0.01% | +25.0% |
| Q3 2022 | $3,476,000 | -26.1% | 56,178 | -4.7% | 0.00% | -20.0% |
| Q2 2022 | $4,704,000 | +325.3% | 58,964 | +460.9% | 0.01% | +400.0% |
| Q1 2022 | $1,106,000 | -7.5% | 10,513 | -5.4% | 0.00% | 0.0% |
| Q4 2021 | $1,196,000 | +4.0% | 11,113 | +5.9% | 0.00% | 0.0% |
| Q3 2021 | $1,150,000 | +20.9% | 10,498 | +3.4% | 0.00% | 0.0% |
| Q2 2021 | $951,000 | +2.3% | 10,152 | +0.5% | 0.00% | 0.0% |
| Q1 2021 | $930,000 | +463.6% | 10,105 | +344.2% | 0.00% | – |
| Q4 2020 | $165,000 | -6.2% | 2,275 | +0.7% | 0.00% | – |
| Q3 2020 | $176,000 | +24.8% | 2,260 | -11.4% | 0.00% | – |
| Q2 2020 | $141,000 | +72.0% | 2,550 | -7.4% | 0.00% | – |
| Q1 2020 | $82,000 | -10.9% | 2,754 | +8.3% | 0.00% | – |
| Q4 2019 | $92,000 | +16.5% | 2,544 | -11.2% | 0.00% | – |
| Q3 2019 | $79,000 | -10.2% | 2,864 | -22.3% | 0.00% | – |
| Q2 2019 | $88,000 | – | 3,687 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |